Is the FDA too cautious? | article by Jerusalem Demsas - Upcarta

Is the FDA too cautious?

Article
Feb 10, 2022
#Covid-19

Jerusalem Demsas

@JerusalemDemsas

Read on www.vox.com

The pandemic revealed the flaws in the FDA’s risk assessments.

Mentions

Alex Tabarrok @ATabarrok · Feb 11, 2022

Post
From Twitter

Excellent piece on the FDA and larger lessons. See the Invisible Graveyard.